Thailand

The key changes concern increased penalties for employers who fail to comply with requirements regarding employment and treatment of minors.

Transparency International has launched its latest 2016 Corruption Perception Index. China’s ranking continues to improve, moving up by four places from last year’s rank of 83 to a rank this year of 79. Find out more about the other highlights.

Baker McKenzie has created a one of its kind Anti-Corruption Risk-Map. The risk maps provide information on primary anti-corruption legislation and enforcement agencies, offences, defences and penalties in 55 countries.

After years of debate and various drafts proposed by interested parties, the Thai Cabinet has finally approved the draft Trade Competition bill.

After several years of development, involving input from over 50 countries, the International Organisation for Standardisation (ISO) has finally published ISO 37001: Anti-Bribery Management Systems Standard - a new international standard designed to assist organisations worldwide in implementing and maintaining effective anti-bribery systems.

The Bank of Thailand has introduced a new regulation to facilitate the Know-Your-Customer process by using an electronic means for account opening for deposit acceptance or fund acceptance from public.

Thailand's Securities and Exchange Commission issued a notification which will cover an immediate ban for directors and executives who are fined by the Criminal Fining Committee based upon inter alia unfair trading offences such as insider trading.

Baker & McKenzie released the 2016 edition of its Global Overview of Anti-Bribery Handbook. You can read the Handbook for free on Global Compliance News.

Thailand's Computer Crime Act B.E. 2550 (2007) addresses computer related issues such as the illegal access to and interference with computer systems and data, the illegal disclosure of security measures, and the illegal interception of computer data.

The Deputy Secretary General of the Food and Drug Administration recently announced that the FDA had received complaints from consumers, asking it to inspect the sale and advertising of drugs on an online shopping website.